(Q41208791)

28 September 2017

title

Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosus (English)

1 reference

28 September 2017

Hammerman C

1

1 reference

28 September 2017

Aramburo MJ

series ordinal

2

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 November 1990

1 reference

The Journal of Pediatrics

28 September 2017

published in

1 reference

28 September 2017

volume

117

1 reference

28 September 2017

issue

5

1 reference

28 September 2017

page(s)

771-776

1 reference

Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983342-6

Clinical evaluation of premature infants with patent ductus arteriosus: a scoring system with echocardiogram, acid-base, and blood gas correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983342-6

Radioimmunoassay techniques for the determination of the local release of prostaglandins and thromboxanes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983342-6

A radioimmunoassay for thromboxane B2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983342-6

Pulsed Doppler echocardiographic determination of time of ductal closure in normal newborn infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983342-6

Recurrence of symptomatic patent ductus arteriosus in extremely premature infants, treated with indomethacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983342-6

Indomethacin treatment in small versus large premature infants with ductus arteriosus. Comparison of plasma indomethacin concentration and clinical response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983342-6

Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983342-6

Factors determining the loss of ductus arteriosus responsiveness to prostaglandin E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983342-6

Persistent responsiveness of the neonatal ductus arteriosus in immature lambs: a possible cause for reopening of patent ductus arteriosus after indomethacin-induced closure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983342-6

The 6-ketoprostaglandin F1alpha pathway in the lamb ductus arteriousus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983342-6

PGE2 is a more potent vasodilator of the lamb ductus arteriosus than is either PGI2 or 6 keto PGFα

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983342-6

The silent ductus: its precursors and its aftermath

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983342-6

Prostaglandin levels: predictors of indomethacin responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983342-6

Effects of prolonged versus acute indomethacin therapy in very low birth-weight infants with patent ductus arteriosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983342-6

Indomethacin therapy for patent ductus arteriosus: when is prophylaxis not prophylactic?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983342-6

Prolonged indomethacin treatment in preterm infants with symptomatic patent ductus arteriosus: efficacy, drug level monitoring, and patient selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983342-6

Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2983342-6

10.1016/S0022-3476(05)83342-6

7 January 2021

Identifiers

DOI

1 reference

28 September 2017

1 reference